FUNCTION OF THE INTERLEUKIN-2 (IL-2) RECEPTOR GAMMA-CHAIN IN BIOLOGIC RESPONSES OF X-LINKED SEVERE COMBINED IMMUNODEFICIENT B-CELLS TO IL-2, IL-4, IL-13, AND IL-15

被引:135
作者
MATTHEWS, DJ
CLARK, PA
HERBERT, J
MORGAN, G
ARMITAGE, RJ
KINNON, C
MINTY, A
GRABSTEIN, KH
CAPUT, D
FERRARA, P
CALLARD, R
机构
[1] INST CHILD HLTH, CELLULAR IMMUNOL UNIT, LONDON WC1N 1EH, ENGLAND
[2] INST CHILD HLTH, MOLEC IMMUNOL UNIT, LONDON, ENGLAND
[3] SANOFI RECH, LABEGE, FRANCE
[4] IMMUNEX CORP, SEATTLE, WA USA
基金
英国惠康基金;
关键词
D O I
10.1182/blood.V85.1.38.bloodjournal85138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interleukin-2 (IL-2) receptor gamma-chain is a common component of several members of the cytokine receptor superfamily including those for IL-2, IL-4, IL-7, IL-9, IL-15, and possibly IL-13, and has recently been renamed the common gamma-chain gamma(c)-chain). Transfection experiments have shown that the gamma(c)-chain participates in signal transduction by IL-2, IL-4 and IL-7, but a functional role for the gamma(c)-chain in biological responses by normal T cells and B cells to these cytokines has not been established. In this study, we have used X-linked severe combined immunodeficiency (X-SCID) as a naturally occurring gamma(c)-chain gene disruption model to examine the role of the gamma(c)-chain in human B-cell responses to IL-2, IL-4, IL-13, and IL-15. Our experiments show that B cells from two X-SCID patients with characterized gamma(c)-chain gene mutations do not respond to IL-2 or IL-15, but respond as well or better than normal B cells to both IL-4 and IL-13 in assays for B cell activation, proliferation, and IgE secretion. This finding raises important questions about the function of the gamma(c)-chain in receptors for IL-4 and IL-13, and the nature of the immune defect in X-SCID. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 27 条
  • [1] RECONSTITUTION OF FUNCTIONAL INTERLEUKIN-2 RECEPTOR COMPLEXES ON FIBROBLASTOID CELLS - INVOLVEMENT OF THE CYTOPLASMIC DOMAIN OF THE GAMMA-CHAIN IN 2 DISTINCT SIGNALING PATHWAYS
    ASAO, H
    TAKESHITA, T
    ISHII, N
    KUMAKI, S
    NAKAMURA, M
    SUGAMURA, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 4127 - 4131
  • [2] AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS
    AVERSA, G
    PUNNONEN, J
    COCKS, BG
    MALEFYT, RD
    VEGA, F
    ZURAWSKI, SM
    ZURAWSKI, G
    DEVRIES, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2213 - 2218
  • [3] CALLARD RE, 1991, CYTOKINES PRACTICAL, P121
  • [4] CLARK PA, 1995, UNPUB HUM MOL GENET
  • [5] NONRANDOM X-CHROMOSOME INACTIVATION IN B-CELLS FROM CARRIERS OF X-CHROMOSOME-LINKED SEVERE COMBINED IMMUNODEFICIENCY
    CONLEY, ME
    LAVOIE, A
    BRIGGS, C
    BROWN, P
    GUERRA, C
    PUCK, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) : 3090 - 3094
  • [6] CONLEY ME, 1992, ANNU REV IMMUNOL, V10, P215
  • [7] THE HEMATOPOIETIN RECEPTOR SUPERFAMILY
    COSMAN, D
    [J]. CYTOKINE, 1993, 5 (02) : 95 - 106
  • [8] INTERLEUKIN-13 IS A B-CELL STIMULATING FACTOR
    DEFRANCE, T
    CARAYON, P
    BILLIAN, G
    GUILLEMOT, JC
    MINTY, A
    CAPUT, D
    FERRARA, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) : 135 - 143
  • [9] ABSENCE OF INTERLEUKIN-2 PRODUCTION IN A SEVERE COMBINED IMMUNODEFICIENCY DISEASE SYNDROME WITH T-CELLS
    DISANTO, JP
    KEEVER, CA
    SMALL, TN
    NICHOLS, GL
    OREILLY, RJ
    FLOMENBERG, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) : 1697 - 1704
  • [10] FISCHER A, 1992, Immunodeficiency Reviews, V3, P83